Latest news about Novateor Research Laboratories
Novateor Research Laboratories
37.50
0.00(0.00%)
Company Performance:
View Company Insights1D0.00%
1M0.00%
6M0.00%
1Y0.00%
5Y+193.20%
More news about Novateor Research Laboratories
15Jun 26
Novateor Research Laboratories launches SmiloShine Herbafresh toothpaste
Novateor Research Laboratories launched SmiloShine Herbafresh Toothpaste in a 6 grams sachet on June 15, 2026. The product, containing 8 herbs, targets the hotel and travel segment to expand the company's domestic and international FMCG footprint.
31May 26
Novateor reports FY26 profit with qualified audit opinion
Novateor Research Laboratories announced its audited standalone financial results for the year and half-year ended March 31, 2026, reporting a net profit of ₹10.12 lakh for the full year. Revenue from operations increased to ₹382.75 lakh from ₹277.73 lakh in the previous year. The statutory auditor, H K Shah & Co., issued a qualified opinion due to non-compliance with AS-2, AS-9, AS-15, and AS-17, specifically regarding inventory valuation, unrealized interest income under legal dispute, lack of gratuity provision, and absence of segment reporting. The board approved the results at a meeting on May 30, 2026.
30Apr 26
Novateor Research Laboratories Launches SmiloShine Herbafresh Toothpaste with 8 Herbs Formulation
Novateor Research Laboratories Limited announced the launch of SmiloShine Herbafresh Toothpaste with 8 herbs formulation on April 30, 2026, as part of its forward integration strategy. The oral care FMCG product will be available in 6-gram packs for hotel and travel segments and 100-gram packs for broader FMCG market penetration. The company has informed BSE Limited about this launch under SEBI Regulation 30, targeting both domestic and international markets with this herbal oral care product.
11Feb 26
Novateor Research Laboratories Launches SmiloShine Aligner and Denture Cleaner Foam
Novateor Research Laboratories Limited launched SmiloShine Aligner and Denture Cleaner and Whitener Foam on February 10, 2026, as announced in a BSE filing on February 11, 2026. The oral care product targets both domestic and international markets and represents a forward integration step for the cosmetic and pharmaceutical company.
04Nov 25
Novateor Research Laboratories Appoints New Company Secretary and Compliance Officer
Novateor Research Laboratories Limited has appointed Mrs. Pooja Bafna Rathi as its new Company Secretary cum Compliance Officer, effective November 3, 2025. Mrs. Rathi, an Associate Company Secretary with diverse qualifications including LLB and M.Com in Business Policy and Corporate Governance, will serve as a Whole Time Key Managerial Personnel. The appointment complies with Section 203 of the Companies Act, 2013, and SEBI regulations. Mrs. Rathi currently holds no shares in the company.
01Oct 25
Novateor Research Laboratories Seeks Shareholder Approval for Business Expansion
Novateor Research Laboratories Limited (BSE: 542771) is seeking shareholder approval to diversify into dental equipment trading and chemicals trading. The company proposes to amend its Memorandum of Association to include these new business activities. For dental equipment, Novateor plans to import, export, distribute, and deal in various dental products and act as a representative for manufacturers. In chemicals, the company aims to trade, formulate, and provide services related to various chemical products. The company held its 14th AGM on September 30 to present these amendments as a special resolution. Mr. Anil Tilakraj Arora has been appointed as a Non-Executive Independent Director for five years. The company has also closed its trading window for insiders in compliance with SEBI regulations.
30Sept 25
Novateor Research Laboratories Appoints Dental Expert Anil Tilakraj Arora as Independent Director
Novateor Research Laboratories Limited (BSE: 542771) has appointed Mr. Anil Tilakraj Arora as a Non-Executive Independent Director for a five-year term, effective September 3, 2025. Mr. Arora, with over 40 years of experience in dentistry, brings expertise from introducing India's largest private dental magazine, hosting major dental exhibitions, and running extensive dental workshops. The appointment, approved at the company's 14th AGM, aligns with corporate governance practices. The AGM also addressed financial statement adoption, director reappointment, and trading window closure for insiders.
Industry Peers
Godrej Consumer Products
Dabur India
Colgate Palmolive
Cupid
Gillette
P&G Hygiene and Health Care
Emami
Mamaearth
Bajaj Consumer Care
Anondita Medicare
840.00
(-1.18%)
374.25
(-1.54%)
1,735.00
(-1.60%)
312.50
(+0.27%)
6,899.00
(-1.44%)
6,639.00
(-2.35%)
372.65
(-1.69%)
427.90
(-0.80%)
497.05
(+0.30%)
1,078.70
(-0.54%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
